Gries Financial LLC Neurocrine Biosciences Inc Transaction History

Gries Financial LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 02, 2024	SELL	$130.86 - $143.19 $5,103 - $5,584	-39 Reduced 1.98%	1,933 $266,000
Q1 2024 May 15, 2024	BUY	$130.4 - $143.74 $13,300 - $14,661	102 Added 5.45%	1,972 $271,000
Q4 2023 Feb 13, 2024	BUY	$106.07 - $132.76 $198,350 - $248,261	1,870 New	1,870 $246,000

625

94.2M

632K

621K

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $12B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

Get notified when there are updates to the investment portfolio of Gries Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Gries Financial LLC with notifications on news.